Drug intelligence / Profile preview

propofol + analgesic drug

Development stage
Unknown
Lead developer
AkzoNobel
Modality
Small Molecules
Administration
Intravenous
01

Overview

This entry refers to a combination therapy of propofol with an analgesic drug, commonly used for procedural sedation and anesthesia. Propofol is an intravenous anesthetic agent that acts primarily as a positive allosteric modulator of the GABA-A receptor, producing sedation and hypnosis. It has rapid onset and offset due to its high lipid solubility and redistribution kinetics. Analgesics frequently combined with propofol include opioids such as fentanyl, remifentanil, or alfentanil (mu-opioid receptor agonists), or dissociative anesthetics like ketamine (NMDA receptor antagonist). The combination allows for synergistic effects—propofol provides hypnosis/sedation while the analgesic addresses pain—enabling lower doses of each agent to be used, which can reduce side effects such as hypotension or respiratory depression[1][6][7]. This approach is widely utilized in emergency medicine and anesthesia for procedures requiring both sedation and pain control.

Other names
ketofol (if the analgesic is ketamine)propofol-fentanylpropofol-remifentanilpropofol-alfentanil (depending on the specific analgesic used)
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)MOR (Mu opioid receptor)GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on propofol + analgesic drug.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on propofol + analgesic drug.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call